Editorial: Next generation MSC therapy manufacturing, potency and mechanism of action analysis

Front Immunol. 2023 Apr 21:14:1192636. doi: 10.3389/fimmu.2023.1192636. eCollection 2023.
No abstract available

Keywords: and regeneration; cell product manufacturing; cell therapy; immunomodulation; mechanism of action (MOA); mesenchymal stromal/stem cells (MSC); potency analysis; safety and efficacy.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Immunomodulation*
  • Mesenchymal Stem Cells*

Grants and funding

GM’s contributions were made possible by the German Research Foundation/Deutsche Forschungsgemeinschaft (DFG; EX-PAND-PD CA2816/1-1) and the German Federal Ministry of Education and Research (BMBF) funding through the BSRT (GSC203) and BCRT, and in part by funding from the European Union’s Horizon 2020 research and innovation program under grant agreements No. 733006 (PACE) and No. 779293 (HIPGEN).